Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: BMcV who wrote (1014)	7/20/1998 8:44:00 PM
From: John Metcalf	Respond to of 10280

I'm not a great fan of stock splits. However, Sepracor did amend the Charter to increase authorized shares from 40mm to 80mm at the annual meeting in May. The most recent 10-Q said that fully diluted shares outstanding would have been reported as 37,812,000 were not the effect of doing so anti-dilutive (viz., would reduce the reported loss per share). One would expect them to leave some shares available for future financing, if needed. Thus a 3:2 split looks more likely than a 2:1.